These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 18940383)
1. Distribution and cardiovascular risk correlates of hemoglobin A(1c) in nondiabetic younger adults: the Bogalusa Heart Study. Nguyen QM; Srinivasan SR; Xu JH; Chen W; Berenson GS Metabolism; 2008 Nov; 57(11):1487-92. PubMed ID: 18940383 [TBL] [Abstract][Full Text] [Related]
2. Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study. Patel DA; Srinivasan SR; Xu JH; Chen W; Berenson GS Metabolism; 2006 Nov; 55(11):1551-7. PubMed ID: 17046560 [TBL] [Abstract][Full Text] [Related]
3. Distribution and metabolic syndrome correlates of plasma C-reactive protein in biracial (black-white) younger adults: the Bogalusa Heart Study. Patel DA; Srinivasan SR; Xu JH; Li S; Chen W; Berenson GS Metabolism; 2006 Jun; 55(6):699-705. PubMed ID: 16713426 [TBL] [Abstract][Full Text] [Related]
4. Distribution and cardiovascular risk correlates of plasma soluble intercellular adhesion molecule-1 levels in asymptomatic young adults from a biracial community: the Bogalusa Heart Study. Nguyen QM; Srinivasan SR; Xu JH; Chen W; Berenson GS Ann Epidemiol; 2010 Jan; 20(1):53-9. PubMed ID: 20006276 [TBL] [Abstract][Full Text] [Related]
5. Genetic and baseline metabolic factors for incident diabetes and HbA(1c) at follow-up: the healthy twin study. Sung J; Lee K; Song YM; Lee M; Kim J Diabetes Metab Res Rev; 2015 May; 31(4):376-84. PubMed ID: 25400114 [TBL] [Abstract][Full Text] [Related]
6. Racial (black-white) divergence in the association between adiponectin and arterial stiffness in asymptomatic young adults: the Bogalusa heart study. Nguyen QM; Srinivasan SR; Xu JH; Chen W; Berenson GS Am J Hypertens; 2008 May; 21(5):553-7. PubMed ID: 18292758 [TBL] [Abstract][Full Text] [Related]
7. Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study. Mattoo V; Eckland D; Widel M; Duran S; Fajardo C; Strand J; Knight D; Grossman L; Oakley D; Tan M; Clin Ther; 2005 May; 27(5):554-67. PubMed ID: 15978304 [TBL] [Abstract][Full Text] [Related]
8. Control of glycemia and other cardiovascular disease risk factors in older adults with type 2 diabetes mellitus: data from the Adult Diabetes Control and Management. Sazlina SG; Mastura I; Ahmad Z; Cheong AT; Adam BM; Jamaiyah H; Lee PY; Syed-Alwi SA; Chew BH; Sriwahyu T Geriatr Gerontol Int; 2014 Jan; 14(1):130-7. PubMed ID: 23581598 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study. Comaschi M; Coscelli C; Cucinotta D; Malini P; Manzato E; Nicolucci A; Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):204-11. PubMed ID: 15955469 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of HbA1c as a marker of circulating lipids in male and female type 2 diabetic patients. Ahmad Khan H Acta Diabetol; 2007 Dec; 44(4):193-200. PubMed ID: 17786383 [TBL] [Abstract][Full Text] [Related]
11. Association of low adiponectin levels with the metabolic syndrome--the Chennai Urban Rural Epidemiology Study (CURES-4). Mohan V; Deepa R; Pradeepa R; Vimaleswaran KS; Mohan A; Velmurugan K; Radha V Metabolism; 2005 Apr; 54(4):476-81. PubMed ID: 15798954 [TBL] [Abstract][Full Text] [Related]
12. Distribution and cardiovascular risk correlates of serum triglycerides in young adults from a biracial community: the Bogalusa Heart Study. Frontini MG; Srinivasan SR; Elkasabany A; Berenson GS Atherosclerosis; 2001 Mar; 155(1):201-9. PubMed ID: 11223443 [TBL] [Abstract][Full Text] [Related]
13. HbA(1c) levels in cardiovascular diseased patients without diabetes in a developing country. Sharma TK; Parchwani H; Kaushik GG; Shankar V; Dahiya K; Ghalaut VS; Sharma N Clin Lab; 2011; 57(7-8):517-22. PubMed ID: 21888015 [TBL] [Abstract][Full Text] [Related]
14. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk). Khaw KT; Wareham N; Luben R; Bingham S; Oakes S; Welch A; Day N BMJ; 2001 Jan; 322(7277):15-8. PubMed ID: 11141143 [TBL] [Abstract][Full Text] [Related]
15. Prediction by Low Plasma HbA1c of Mortality, Cardiac and Noncardiac Disease Risk: Modulation by Diabetic Status and Sex. Altay S; Onat A; Karadeniz Y; Ă–zpamuk-Karadeniz F; Can G J Investig Med; 2015 Aug; 63(6):821-7. PubMed ID: 26107424 [TBL] [Abstract][Full Text] [Related]
16. Utility of waist-to-height ratio in detecting central obesity and related adverse cardiovascular risk profile among normal weight younger adults (from the Bogalusa Heart Study). Srinivasan SR; Wang R; Chen W; Wei CY; Xu J; Berenson GS Am J Cardiol; 2009 Sep; 104(5):721-4. PubMed ID: 19699351 [TBL] [Abstract][Full Text] [Related]
17. Nutrient intakes; biochemical and risk indices associated with Type 2 diabetes and glycosylated haemoglobin, in the British National Diet and Nutrition Survey of people aged 65 years and over. Bates CJ; Lean ME; Mansoor MA; Prentice A Diabet Med; 2004 Jul; 21(7):677-84. PubMed ID: 15209758 [TBL] [Abstract][Full Text] [Related]
18. Differential impact of serum glucose, triglycerides, and high-density lipoprotein cholesterol on cardiovascular risk factor burden in nondiabetic, obese African American women: implications for the prevalence of metabolic syndrome. Gaillard T; Schuster D; Osei K Metabolism; 2010 Aug; 59(8):1115-23. PubMed ID: 20051282 [TBL] [Abstract][Full Text] [Related]
19. Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study. Patel DA; Srinivasan SR; Xu JH; Chen W; Berenson GS Metabolism; 2007 Jun; 56(6):792-8. PubMed ID: 17512312 [TBL] [Abstract][Full Text] [Related]
20. The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Gerstein HC; Swedberg K; Carlsson J; McMurray JJ; Michelson EL; Olofsson B; Pfeffer MA; Yusuf S; Arch Intern Med; 2008 Aug; 168(15):1699-704. PubMed ID: 18695086 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]